COVID-19: implications for immunosuppression in kidney disease and transplantation.,Nature Reviews Nephrology

当前位置： X-MOL 学术 › Nat. Rev. Nephrol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

COVID-19: implications for immunosuppression in kidney disease and transplantation.
Nature Reviews Nephrology ( IF 41.5 ) Pub Date : 2020-05-14 , DOI: 10.1038/s41581-020-0305-6
Andreas Kronbichler ₁ , Philipp Gauckler ₁ , Martin Windpessl _{2,

3} , Jae Il Shin _{4,

5,

6} , Vivekanand Jha _{7,

8,

9} , Brad H Rovin ₁₀ , Rainer Oberbauer ₁₁

Affiliation

Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.
Department of Internal Medicine IV, Section of Nephrology, Klinikum Wels-Grieskirchen, Wels, Austria.
Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea.
Division of Pediatric Nephrology, Severance Children's Hospital, Seoul, Republic of Korea.
Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Republic of Korea.
George Institute for Global Health, UNSW, New Delhi, India.
George Institute for Global Health, University of Oxford, Oxford, UK.
Manipal Academy of Higher Education, Manipal, India.
Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Department of Nephrology, Medical University of Vienna, Vienna, Austria.

The coronavirus disease 2019 (COVID-19) pandemic poses important challenges to the care of patients with immune-mediated kidney diseases and to kidney transplant recipients. Here, we discuss the management of immunosuppression for these patients during the pandemic and suggest potential approaches that could be considered in the absence of validated strategies.

中文翻译：